Tremfya Market: Role of Biologic Therapies and Expanding Indications
The Tremfya market was valued at USD 4.2 billion in 2025 and is projected to reach USD 7.99 billion by 2034, growing at a CAGR of 7.40% from 2026 to 2034, according to Polaris Market Research. Several factors support this growth: a rising preference for biologic therapies over traditional systemic treatments, higher healthcare spending, and better access to specialty medicines. Tremfya...
0 Σχόλια 0 Μοιράστηκε 19 Views 0 Προεπισκόπηση